These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26686908)

  • 1. The complement system in cancer: Ambivalence between tumour destruction and promotion.
    Mamidi S; Höne S; Kirschfink M
    Immunobiology; 2017 Jan; 222(1):45-54. PubMed ID: 26686908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.
    Meyer S; Leusen JH; Boross P
    MAbs; 2014; 6(5):1133-44. PubMed ID: 25517299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies.
    Taylor RP; Lindorfer MA
    Semin Immunol; 2016 Jun; 28(3):309-16. PubMed ID: 27009480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement as a Biological Tool to Control Tumor Growth.
    Macor P; Capolla S; Tedesco F
    Front Immunol; 2018; 9():2203. PubMed ID: 30319647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of antibody isotypes in antitumor immunity by monocytes and complement using human-immune tumor models.
    Lara S; Anania JC; Virtanen A; Stenhammar V; Kleinau S
    Eur J Immunol; 2021 May; 51(5):1218-1233. PubMed ID: 33533020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementing the Cancer-Immunity Cycle.
    Pio R; Ajona D; Ortiz-Espinosa S; Mantovani A; Lambris JD
    Front Immunol; 2019; 10():774. PubMed ID: 31031765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils as effector cells for antibody-based immunotherapy of cancer.
    van Egmond M; Bakema JE
    Semin Cancer Biol; 2013 Jun; 23(3):190-9. PubMed ID: 23287459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual role of complement in tumour growth and metastasis (Review).
    Stover C
    Int J Mol Med; 2010 Mar; 25(3):307-13. PubMed ID: 20127033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement as effector system in cancer immunotherapy.
    Macor P; Tedesco F
    Immunol Lett; 2007 Jul; 111(1):6-13. PubMed ID: 17572509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: The Role of Complement in Tumors.
    Rolfe BE; Pio R; Woodruff TM; Markiewski MM; Manthey HD
    Front Immunol; 2020; 11():139. PubMed ID: 32117286
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement function in mAb-mediated cancer immunotherapy.
    Gelderman KA; Tomlinson S; Ross GD; Gorter A
    Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044
    [No Abstract]   [Full Text] [Related]  

  • 12. New perspectives on complement mediated immunotherapy.
    Stasiłojć G; Österborg A; Blom AM; Okrój M
    Cancer Treat Rev; 2016 Apr; 45():68-75. PubMed ID: 26994325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated complement activation in pathology and protection.
    Goldberg BS; Ackerman ME
    Immunol Cell Biol; 2020 Apr; 98(4):305-317. PubMed ID: 32142167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application.
    Luo S; Wang M; Wang H; Hu D; Zipfel PF; Hu Y
    Front Immunol; 2020; 11():593610. PubMed ID: 33193442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement in antibody-based tumor therapy.
    Derer S; Beurskens FJ; Rosner T; Peipp M; Valerius T
    Crit Rev Immunol; 2014; 34(3):199-214. PubMed ID: 24941073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting complement-mediated immunoregulation for cancer immunotherapy.
    Kolev M; Markiewski MM
    Semin Immunol; 2018 Jun; 37():85-97. PubMed ID: 29454575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement System: a Neglected Pathway in Immunotherapy.
    Bordron A; Bagacean C; Tempescul A; Berthou C; Bettacchioli E; Hillion S; Renaudineau Y
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):155-171. PubMed ID: 31144209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of membrane glycoproteins CD46, CD55 and CD59 in protection of tumor cells against complement lysis].
    Wojnicz D; Bar J; Jankowski S
    Postepy Hig Med Dosw; 2002; 56(5):603-16. PubMed ID: 12587428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement disorders and hereditary angioedema.
    Frank MM
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S262-71. PubMed ID: 20176263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of complement in mAb-based therapies of cancer.
    Taylor RP; Lindorfer MA
    Methods; 2014 Jan; 65(1):18-27. PubMed ID: 23886909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.